Cephalexin for Skin Wound Infections
Cephalexin is an appropriate and effective first-line antibiotic for uncomplicated skin wound infections caused by methicillin-susceptible Staphylococcus aureus (MSSA) and Streptococcus species.
Guideline-Based Recommendations
The IDSA guidelines explicitly list cephalexin as a recommended oral agent for skin and soft tissue infections (SSTIs), with dosing of 500 mg four times daily for adults and 25-50 mg/kg/day in 3-4 divided doses for children 1. Cephalexin is specifically indicated for:
- Impetigo caused by Staphylococcus and Streptococcus 1
- MSSA SSTIs where it serves as an oral agent of choice, particularly in pediatrics due to suspension availability and less frequent dosing requirements 1
When to Use Cephalexin
Cephalexin is appropriate when:
- The infection is uncomplicated (no systemic signs like fever >38°C, tachycardia >90 bpm, or hypotension) 1
- MRSA is not suspected or the patient has failed initial therapy 1
- The wound is a simple traumatic wound or laceration, even if highly contaminated 2
Clinical Efficacy Evidence
High-quality comparative trials demonstrate cephalexin's effectiveness:
- Cephalexin achieved 89-100% clinical cure rates for uncomplicated SSTIs, equivalent to IV cefazolin plus probenecid 3
- In a large randomized trial, cephalexin showed 85.5% clinical cure for cellulitis, non-inferior to combination therapy 4
- Cephalexin was as effective as newer broad-spectrum agents (moxifloxacin, cefdinir) with >90% clinical response rates 5, 6, 7
Important Limitations and Caveats
MRSA considerations: While cephalexin lacks in vitro activity against MRSA, some studies paradoxically showed clinical response rates of 90-92% for MRSA infections 6. However, this likely reflects the contribution of incision and drainage rather than antibiotic activity 6. Do not rely on cephalexin alone for suspected MRSA infections - the IDSA recommends MRSA-active agents (clindamycin, trimethoprim-sulfamethoxazole, doxycycline) when MRSA is suspected 1.
Prescribing principles from FDA labeling:
- Only prescribe for proven or strongly suspected bacterial infections to prevent resistance 8
- Monitor patients on metformin closely, as cephalexin increases metformin levels by 24-34% 8
- Use caution in patients with renal impairment, GI disease history, or on anticoagulants 8
Practical Dosing Strategies
Standard dosing: 500 mg four times daily for 7 days in adults 1, 3
Shorter duration for prophylaxis: For contaminated traumatic wounds, 2 days of prophylactic cephalexin is as effective as 5 days (8.57% vs 7.14% infection rates, p=0.31) 2
Less frequent dosing for adherence: While four-times-daily dosing is standard, twice-daily or three-times-daily regimens may be considered in pediatric populations to improve compliance, though specific dosing adjustments are required 9
Key Clinical Pitfalls
- Do not use cephalexin if the patient has signs of systemic infection (SIRS criteria), failed initial therapy, or has immunocompromise - these require MRSA coverage 1
- Ensure surgical intervention (incision and drainage) is performed when indicated, as antibiotics alone are insufficient for abscesses 1
- Complete the full course even if symptoms improve early, as incomplete treatment increases resistance risk 8
- Watch for C. difficile infection, which can occur up to 2 months after antibiotic completion 8